🇺🇸 FDA

Company profile · Sponsor

Cartesian

Cartesian Therapeutics

RNAC · NYSE pharma FREDERICK, MD, USA
Pipeline
12
Drugs
0
Patents
4

Quick answer

Cartesian (RNAC) is a pharma company. headquartered in FREDERICK, MD, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker RNAC
Exchange NYSE
Company type pharma
Headquarters FREDERICK, MD, USA
SEC CIK 0001453687

Pipeline (12)

Search pipeline →

  1. Decartes-08

    Cartesian

    Myasthaenia Gravis

    phase 3 mab active

    1 trial

  2. Placebo to Descartes-08, Descartes-08

    Cartesian

    generalized myasthenia gravis

    phase 3 small molecule active

    1 trial

  3. Descartes 08

    Cartesian

    Myeloma Multiple

    phase 2 mab terminated

    1 trial

  4. Descartes-08

    Cartesian

    Childhood-onset Systemic Lupus Erythematous

    phase 2 small molecule active

    1 trial

  5. Descartes-08

    Cartesian

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial

  6. Descartes-08

    Cartesian

    Antisynthetase Syndrome

    phase 2 small molecule active

    1 trial

  7. Descartes-08

    Cartesian

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule active

    1 trial

  8. Descartes-11

    Cartesian

    Multiple Myeloma

    phase 2 mab terminated

    2 trials

  9. Descartes 30

    Cartesian

    Acute Respiratory Distress Syndrome

    phase 1 mab terminated

    1 trial

  10. Descartes-08

    Cartesian

    Multiple Myeloma

    phase 1 mab terminated

    1 trial

  11. Descartes-15

    Cartesian

    Refractory Multiple Myeloma

    phase 1 small molecule terminated

    1 trial

  12. Descartes-25

    Cartesian

    Multiple Myeloma

    phase 1 small molecule terminated

    1 trial

Patents (4)

Search patents →

  1. US 12194078

    Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11999773

    Anti-BCMA chimeric antigen receptors

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11220535

    Anti-BCMA chimeric antigen receptors

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10934337

    Anti-BCMA chimeric antigen receptors

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Cartesian?

Cartesian (RNAC) is a pharma company. headquartered in FREDERICK, MD, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does Cartesian sponsor?

We track 12 ClinicalTrials.gov-linked programs for Cartesian, including Decartes-08 and 11 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Cartesian company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.